Oral Health Group


March 7, 2012 News PharmacologyPharmacotherapeutics

Statins and Diabetes: Real Concern or Much Ado About Nothing?

by ken

From Forbes In a New York Times Op-Ed piece on Monday, Eric Topol comments on last week’s announcement by the FDA that it was changing the label for statins. Topol focuses on the new warning that statins raise the risk of diabetes. He

December 21, 2011 News PharmacotherapeuticsSystemic links

Studies Suggest an Acetaminophen-Asthma Link

by ken

The sharp worldwide increase in childhood asthma over the past 30 years has long perplexed researchers, who have considered explanations as varied as improved hygiene and immunizations. Over the last decade, however, a new idea has emerged. The asthma epidemic

December 17, 2011 News Pharmacotherapeutics

Treating dental patients who use oral antithrombotic medication – survey of dentists in the Netherlands

by ken

Abstract DE van Diermen et al From JADA – Dec 2011 Background. For many years, international guidelines have advised health care professionals not to adjust oral antithrombotic medication (OAM) regimens before invasive dental procedures. The authors conducted a study to examine

November 6, 2011 News BlogsBotoxBurn outCAD/CAMCajonesCancerChronic dental care for the elderlyClinical case report - prostho/orthoCloud computingCommunity outreachComprehensive reasoningComputer softwareCone beam computed tomographyConnectivityContinuing EducationCosmetic DentistryCranio facial painCustomer serviceData storageDecay assessment and preventionDental amalgamDental AssociationsDental conventionsDental equipmentDental ethicsDental examinationDental HygieneDental industryDental LaboratoriesDental phobiaDental photographyDental practice transitionDental researchDental TeamDental TraumaDentoMaxilloFacialRadiologyDigital radiographyElearningElectronic Health RecordsEndodonticsEvidence based dentistryFluorideGeneral NewsGeriodonticsGovernanceGovernment regulationsHealth care tourismHumourImplantologyInfection controlInnovations in dentistryInvisalignLaser DentistryMarketing strategiesMinimally invasive dentistryNew TechnologiesOcclusionOffice designOral cancerOral SurgeryOrthodonticsPain managementPathologyPediatric dentistryPeriodontologyPharmacologyPharmacotherapeuticsPhotographyPosition paperPractice managementPreventive DentistryPrivacy issuesRadiologyRepetitive stress injuryResearchRestorativeSalivary biomarkersSearch engineSleep apneaSocial mediaSocial networkingStem cell researchSystemic linksTeam motivationTechnologyTheft in the dental officeTooth decayTooth whiteningTradeshowsTreatment planningTrends in Dental EducationTrends in DentistryWebinarsWebsitesWomen in dentistryYouTube

There is a god; we made the New York Times Sunday Review

by ken

IT’S become commonplace to criticize the “Occupy” movement for failing to offer an alternative vision. But the thousands of activists in the streets of New York and London aren’t the only ones lacking perspective: economists, to whom we might expect

November 3, 2011 News Pediatric dentistryPharmacologyPharmacotherapeutics

Antibiotics: Use and misuse in pediatric dentistry

by ken

From Marty Jablow DMD – Dental News and Technology Peedikayil FC. Antibiotics: Use and misuse in pediatric dentistry. J Indian Soc Pedod Prev Dent 2011;29:282-7  Antibiotics are commonly used in dentistry for prophylactic as well as for therapeutic purposes. Most

November 1, 2011 News PharmacologyPharmacotherapeutics

Over-the-Counter Ibuprofen and Acetaminophen in Combination are Superior to Each Agent Alone in Treating Postoperative Pain

by ken

Sorry about the length but as I’ve indicated in the past…….no archive, no Word Press…..SOB!!!!!  Also can’t paste Dr. Wynn’s image – sharp looking dude, again NO WORD PRESS………..SOBBBB!!!!! Dr. Richard L. Wynn is Professor of Pharmacology at the University of

October 20, 2011 News ImplantologyOrthodonticsPharmacologyPharmacotherapeutics

See me, feel me, touch me, heal me

by ken

Before you read any further, please check out the website http://www.mis-implants.com/ – “some” companies are gittin’ it…….now to the point…… From Dr. Bicuspid October 18, 2011 — What can you do for a patient whose braces are shredding the inside of their

July 2, 2011 News PharmacologyPharmacotherapeutics

Tylenol 3 is such an ‘ugly’ drug

by ken

From Science Daily – July1, 2011 In the cover article of this month’s Journal of the American Dental Association, a group of nine dentists, pharmacists, and addiction experts provides new research and recommendations to help dentists combat, rather than contribute to, abuse

April 27, 2011 News Decay assessment and preventionPharmacotherapeutics

Oragenics – Innovative Biopharmaceuticals from Oral Science

by ken

A long time ago in a galaxy far, far away, I had the opportunity to go to graduate school at the Harvard/Forsyth Dental Center. It is the research home to many brilliant minds in dentistry, mine unfortunately was not one

April 24, 2011 News General NewsNew TechnologiesPathologyPharmacologyPharmacotherapeuticsSystemic links

I hate your guts takes on a whole new meaning – Bacterial Ecosystems Divide People Into 3 Groups, Scientists Say

by ken

BY it, Dr.” defer=”defer”>

March 24, 2011 News General NewsPharmacotherapeutics

UK woman dies in dentist’s chair after allergic reaction

by ken

Published March 23, 2011 NewsCore   An investigation is underway into the death of a British woman who collapsed in the dentist’s chair after using mouthwash. Sacha Rumaner, 30, from Brighton, in southern England, was having her teeth cleaned at

November 25, 2010 News PharmacotherapeuticsPractice managementSocial networking

New England Journal of Medicine – Social Media is in the BIBLE

by ken

By Jeremy A. Greene, M.D., Ph.D., and Aaron S. Kesselheim, M.D., J.D., M.P.H. Facebook and Twitter, the largest social media Web sites, have more than 350 million users worldwide, and surveys indicate that 60% of Americans turn first to the

November 1, 2010 News Pharmacotherapeutics

The Incidence of Osteonecrosis of the Jaw in Patients Receiving 5 Milligrams of Zoledronic Acid

by ken

Data From the Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly Clinical Trials Program John T. Grbic, DMD, MS,MMedSc,Dennis M. Black, PhD, Kenneth W. Lyles, MD, David M. Reid, MD, Eric Orwoll, MD, Michael McClung, MD, Christina Bucci-Rechtweg,